Modulating effects of spirulina platensis against tilmicosin-induced cardiotoxicity in mice

Cell Journal

Volumn 17, Issue 1, 2015, Pages 137-144

  Ibrahim, Abdelaziz E ^a   Abdel Daim, Mohamed Mohamed ^a  

^a Suez Canal University   (Egypt)

Author keywords

Antioxidant; Heart; Oxidative stress; Spirulina; Tilmicosin

Indexed keywords

ANTIOXIDANT; CARDIOVASCULAR AGENT; CATALASE; CREATINE KINASE; CREATINE KINASE MB; GLUTATHIONE; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; LIPID; MALONALDEHYDE; PROTECTIVE AGENT; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TILMICOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTHROSPIRA PLATENSIS; ARTICLE; CARDIOTOXICITY; CLINICAL EVALUATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE REGIMEN; FREE RADICAL SCAVENGING ASSAY; HEART INJURY; HEART PROTECTION; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TREATMENT RESPONSE;

EID: 84904109691     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Modric S, Webb AI, Derendorf H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J Vet Pharmacol Ther. 1998; 21(6): 444-452.
2. Vogel GJ, Laudert SB, Zimmermann A, Guthrie CA, Mechor GD, Moore GM. Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle. J Am Vet Med Assoc. 1998; 212(12): 1919-1924.
3. Naccari F, Giofre F, Pellegrino M, Calo M, Licata P, Carli S. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep. Vet Rec. 2001; 148(25): 773-776.
4. Dingwell RT, Duffield TF, Leslie KE, Keefe GP, DesCoteaux L, Kelton DF, et al. The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period. J Dairy Sci. 2002; 85(12): 3250-3259.
5. Dingwell RT, Leslie KE, Duffield TF, Schukken YH, DesCoteaux L, Keefe GP, et al. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J Dairy Sci. 2003; 86(1): 159-168.
6. Croft A, Duffield T, Menzies P, Leslie K, Bagg R, Dick P. The effect of tilmicosin administered to ewes prior to lambing on incidence of clinical mastitis and subsequent lamb performance. Can Vet J. 2000; 41(4): 306-311.
7. Fricke JA, Clark CR, Boison JO, Chirino-Trejo M, Inglis TE, Dowling PM. Pharmacokinetics and tissue depletion of tilmicosin in turkeys. J Vet Pharmacol Ther. 2008; 31(6): 591-594.
8. Abu-Basha EA, Idkaidek NM, Al-Shunnaq AF. Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens. Vet Res Commun. 2007; 31(4): 477-485.
9. Jordan FT, Forrester CA, Hodge A, Reeve-Johnson LG. The comparison of an aqueous preparation of tilmicosin with tylosin in the treatment of Mycoplasma gallisepticum infection of turkey poults. Avian Dis. 1999; 43(3): 521-525.
10. Hartman EG, Geryl J. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates. Vet Q. 1993; 15(4): 184.
11. Ramadan A. Pharmacokinetics of tilmicosin in serum and milk of goats. Res Vet Sci. 1997; 62(1): 48-50.
12. Ziv G, Shem-Tov M, Glickman A, Winkler M, Saran A. Tilmicosin antibacterial activity and pharmacokinetics in cows. J Vet Pharmacol Ther. 1995; 18(5): 340-345.
13. Scorneaux B, Shryock TR. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. J Dairy Sci. 1999; 82(6): 1202-1212.
14. Jordan WH, Byrd RA, Cochrane RL, Hanasono GK, Hoyt JA, Main BW, et al. A review of the toxicology of the antibiotic MICOTIL 300. Vet Hum Toxicol. 1993; 35(2): 151-158.
15. Main BW, Means JR, Rinkema LE, Smith WC, Sarazan RD. Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs. J Vet Pharmacol Ther. 1996; 19(3): 225-232.
16. Yazar E, Altunok V, Elmas M, Tras B, Bas AL, Ozdemir V. The effect of tilmicosin on cardiac superoxide dismutase and glutathione peroxidase activities. J Vet Med B Infect Dis Vet Public Health. 2002; 49(4): 209-210.
17. Altunok V, Yazar E, Elmas M, Tras B, Bas AL, Col R. Investigation of haematological and biochemical side effects of tilmicosin in healthy New Zealand rabbits. J Vet Med B Infect Dis Vet Public Health. 2002; 49(2): 68-70.
18. Von-Essen S, Spencer J, Hass B, List P, Seifert SA. Unintentional human exposure to tilmicosin (Micotil 300). J Toxicol Clin Toxicol. 2003; 41(3): 229-233.
19. Kart A, Yapar K, Karapehlivan M, Citil M. The possible protective effect of L-carnitine on tilmicosin-induced cardiotoxicity in mice. J Vet Med A Physiol Pathol Clin Med. 2007; 54(3): 144-146.
20. Khan Z, Bhadouria P, Bisen PS. Nutritional and therapeutic potential of Spirulina. Curr Pharm Biotechnol. 2005; 6(5): 373-379.
21. Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V. C-phycocyanin: A biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci. 2003; 4(3): 207-216.
22. Reddy CM, Bhat VB, Kiranmai G, Reddy MN, Reddanna P, Madyastha KM. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun. 2000; 277(3): 599-603.
23. Basha OM, Hafez RA, El-Ayouty YM, Mahrous KF, Bareedy MH, Salama AM. C-Phycocyanin inhibits cell proliferation and may induce apoptosis in human HepG2 cells. Egypt J Immunol. 2008; 15(2): 161-167.
24. Mohan IK, Khan M, Shobha JC, Naidu MU, Prayag A, Kuppusamy P, et al. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother Pharmacol. 2006; 58(6): 802-808.
25. Khan M, Shobha JC, Mohan IK, Rao Naidu MU, Prayag A, Kutala VK. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. J Appl Toxicol. 2006; 26(5): 444-451.
26. Khan M, Varadharaj S, Shobha JC, Naidu MU, Parinandi NL, Kutala VK, et al. C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes. J Cardiovasc Pharmacol. 2006; 47(1): 9-20.
27. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. Protective effect of Spirulina fusiformis on chemical-induced genotoxicity in mice. Fitoterapia. 2004; 75(1): 24-31.
28. Gad AS, Khadrawy YA, El-Nekeety AA, Mohamed SR, Hassan NS, Abdel-Wahhab MA. Antioxidant activity and hepatoprotective effects of whey protein and Spirulina in rats. Nutrition. 2011; 27(5): 582-589.
29. Vadiraja BB, Gaikwad NW, Madyastha KM. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem Biophys Res Commun. 1998; 249(2): 428-431.
30. Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, et al. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity. Phytother Res. 2005; 19(12): 1030-1037.
31. Gantar M, Dhandayuthapani S, Rathinavelu A. Phycocyanin induces apoptosis and enhances the effect of topotecan on prostate cell line LNCaP. J Med Food. 2012; 15(12): 1091-1095.
32. Nishanth RP, Ramakrishna BS, Jyotsna RG, Roy KR, Reddy GV, Reddy PK, et al. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line. Eur J Pharmacol. 2010; 649(1-3): 74-83.
33. Buhl SN, Jackson KY. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem. 1978; 24(5): 828-831.
34. Szasz G, Waldenstrom J, Gruber W. Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components. Clin Chem. 1979; 25(3): 446-452.
35. Wurzburg U, Hennrich N, Lang H, Prellwitz W, Neumeier D, Knedel M. [Determination of creatine kinase-MB in serum using inhibiting antibodies (author's transl)]. Klin Wochenschr. 1976; 54(8): 357-360.
36. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86(1): 271-278.
37. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963; 61: 882-888.
38. Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972; 46(2): 849-854.
39. Aebi H. Catalase in vitro. Methods Enzymol. 1984; 105: 121-126.
40. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001; 54(5): 356-361.
41. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med. 1990; 8(6): 583-599.
42. Madkour FF, Abdel-Daim MM. Hepatoprotective and antioxidant activity of dunaliella salina in paracetamol-induced acute toxicity in rats. Indian J Pharm Sci. 2013; 75(6): 642-648.
43. Farber JL. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect. 1994; 102 Suppl 10: 17-24.
44. Abdel-Daim M, Funasaka Y, Kamo T, Ooe M, Matsunaka H, Yanagita E, et al. Preventive effect of chemical peeling on ultraviolet induced skin tumor formation. J Dermatol Sci. 2010; 60(1): 21-28.
45. Hogg N. Free radicals in disease. Semin Reprod Endocrinol. 1998; 16(4): 241-248.
46. Azab S, Abdel-Daim M, Eldahshan O. Phytochemical, cytotoxic, hepatoprotective and antioxidant properties of Delonix regia leaves extract. Med Chem Res. 2013; 22(9): 4269-4277.
47. Funasaka Y, Abdel-Daim M, Kawana S, Nishigori C. Effect of chemical peeling on the skin in relation to UV irradiation. Exp Dermatol. 2012; 21 Suppl 1: 31-35.
48. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis. 1996; 14: 131-159.
49. Guo D, Cai Y, Chai D, Liang B, Bai N, Wang R. The cardiotoxicity of macrolides: A systematic review. Pharmazie. 2010; 65(9): 631-640.
50. Tamargo J, De-Miguel B, Tejerina MT. A comparison of josamycin with macrolides and related antibiotics on isolated rat atria. Eur J Pharmacol. 1982; 80(4): 285-293.
51. Boddeke HW, Wilffert B, Heynis JB, van- Zwieten PA. In-vestigation of the mechanism of negative inotropic activity of some calcium antagonists. J Cardiovasc Pharmacol. 1988; 11(3): 321-325.
52. McGuigan MA. Human exposures to tilmicosin (MICOTIL). Vet Hum Toxicol. 1994; 36(4): 306-308.
53. Christodoulopoulos G. Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects. Can Vet J. 2009; 50(1): 61-63.
54. Upasani CD, Balaraman R. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother Res. 2003; 17(4): 330-334.
55. Abdel-Daim MM, Abuzead SM, Halawa SM. Protective role of Spirulina platensis against acute deltamethrin-induced toxicity in rats. PloS One. 2013; 8(9): e72991.
56. Kuriakose GC, Kurup MG. Antioxidant and antihepatotoxic effect of Spirulina laxissima against carbon tetrachloride induced hepatotoxicity in rats. Food Funct. 2011; 2(3-4): 190-196.
57. Avdagic N, Cosovic E, Nakas-Icindic E, Mornjakovic Z, Zaciragic A, Hadzovic-Dzuvo A. Spirulina platensis protects against renal injury in rats with gentamicin-induced acute tubular necrosis. Bosn J Basic Med Sci. 2008; 8(4): 331-336.
58. Karadeniz A, Yildirim A, Simsek N, Kalkan Y, Celebi F. Spirulina platensis protects against gentamicin-induced nephrotoxicity in rats. Phytother Res. 2008; 22(11): 1506-1510.
59. Banji D, Banji OJ, Pratusha NG, Annamalai AR. Investigation on the role of Spirulina platensis in ameliorating behavioural changes, thyroid dysfunction and oxidative stress in offspring of pregnant rats exposed to fluoride. Food Chem. 2013; 140(1-2): 321-331.
60. Gargouri M, Ghorbel-Koubaa F, Bonenfant-Magne M, Magne C, Dauvergne X, Ksouri R, et al. Spirulina or dandelion-enriched diet of mothers alleviates lead-induced damages in brain and cerebellum of newborn rats. Food Chem Toxicol. 2012; 50(7): 2303-2310.
61. Karadeniz A, Cemek M, Simsek N. The effects of Panax ginseng and Spirulina platensis on hepatotoxicity induced by cadmium in rats. Ecotoxicol Environ Saf. 2009; 72(1): 231-235.
62. Ishimi Y, Sugiyama F, Ezaki J, Fujioka M, Wu J. Effects of Spirulina, a blue-green alga, on bone metabolism in ovariectomized rats and hindlimb-unloaded mice. Biosci Biotechnol Biochem. 2006; 70(2): 363-368.
63. Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, et al. United States pharmacopeia safety evaluation of Spirulina. Crit Rev Food Sci Nutr. 2011; 51(7): 593-604.